Cipla’s arm concludes acquisition of South Africa based Anmarate

13 Apr 2017 Evaluate

Cipla’s wholly owned subsidiary - Cipla Medpro South Africa has completed the acquisition of Anmarate, South Africa on April 12, 2017. Earlier, Cipla Medpro South Africa had signed an agreement on March 2017 to acquire 100% stake in Anmarate, South Africa.

Anmarate, incorporated in 1996 in South Africa, is engaged in manufacturing and distribution of pharmaceutical products.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For 80 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 100 countries.

Cipla Share Price

1400.00 52.30 (3.88%)
24-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1486.35
Dr. Reddys Lab 5962.50
Cipla 1400.00
Zydus Lifesciences 933.40
Lupin 1580.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.